COMM vs REGN · P/E 17, rev $4.21B vs P/E 14, rev $14.34B
CommScope Holding Co Inc (COMM) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
CommScope Holding Co Inc (COMM) is a communication equipment company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported COMM revenue for 2024-12-31 was $4.21B. Net income was -$315.5M. Revenue was down 7.9% from 2023-12-31 to 2024-12-31. COMM currently screens at market cap $4.34B and trailing P/E 16.7.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
COMM currently screens at market cap $4.34B and trailing P/E 16.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the COMM and REGN stock pages for the full models.
Not investment advice.